Newsfeeds - Spark Newswire

1 minute read

Taiwan-Based Formosa Pharmaceuticals Has Entered Into A Collaboration Agreement With Eyenovia For The Development Of Ophthalmic Therapeutics. Deal Terms Not Disclosed

Today, 6:44 AM

The collaboration will combine Formosa's proprietary APNT nanoparticle formulation platform with Eyenovia's Optejet dispensing technology for the development of new ophthalmic therapies

EYEN

8 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 6:44 AM

On Thursday, 116 companies set new 52-week lows.

AHPI

1 minute read

Eyenovia Files Prospectus Related To Offer, Sale By Selling Stockholders Of Up To 2.9M Shares Of Common Stock

By Michael Horton

Today, 6:44 AM

-SEC Filing

EYEN

1 minute read

Eyenovia Q3 EPS $(0.21) Misses $(0.20) Estimate

By Benzinga Newsdesk

Today, 6:44 AM

Eyenovia (NASDAQ:EYEN) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.20) by 5 percent. This is unchanged from the same period last year.

EYEN

1 minute read

Earnings

Earnings Outlook For Eyenovia

By Benzinga Insights

Today, 6:44 AM

Eyenovia (NASDAQ:EYEN) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that Eyenovia will report an earnings per share (EPS) of $-0.20.

EYEN

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

Today, 6:44 AM

Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value of their outstanding shares is at $96.2 million.

ANPC

2 minute read

Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket

By Lisa Levin

Today, 6:44 AM

Gainers

ACA

1 minute read

HC Wainwright Initiates This Eye-Focused Stock With Almost 400% Upside

By Vandana Singh

Today, 6:44 AM

HC Wainwright Matthew Caufield initiated coverage on Eyenovia Inc (NASDAQ:EYEN), focused on developing ophthalmic therapeutics based on the company’s microdose array…

EYEN

1 minute read

HC Wainwright & Co. Initiates Coverage On Eyenovia with Buy Rating, Announces Price Target of $12

By Benzinga Newsdesk

Today, 6:44 AM

HC Wainwright & Co. analyst Matthew Caufield initiates coverage on Eyenovia (NASDAQ:EYEN) with a Buy rating and announces Price Target of $12.

EYEN

6 minute read

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:44 AM

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.

AEO